Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong
· Delayed Price · Currency is HKD 1.160
+0.010 (0.87%)
At close: Mar 10, 2026
HKG:2348 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,744 | 1,832 | 1,575 | 1,993 | 2,502 | 2,107 | Upgrade
|
| Market Cap Growth | -3.23% | 16.32% | -20.98% | -20.34% | 18.77% | -5.13% | Upgrade
|
| Enterprise Value | -22 | 221 | 503 | 1,004 | 1,638 | 1,060 | Upgrade
|
| Last Close Price | 1.16 | 1.12 | 0.90 | 1.07 | 1.25 | 0.98 | Upgrade
|
| PE Ratio | 9.03 | 3.05 | 4.39 | 4.93 | 5.69 | 6.62 | Upgrade
|
| Forward PE | - | 8.59 | 8.59 | 8.59 | 8.59 | 8.59 | Upgrade
|
| PS Ratio | 1.43 | 1.62 | 1.24 | 1.38 | 1.75 | 1.73 | Upgrade
|
| PB Ratio | 0.48 | 0.52 | 0.50 | 0.67 | 0.85 | 0.81 | Upgrade
|
| P/TBV Ratio | 0.57 | 0.59 | 0.58 | 0.77 | 1.00 | 0.94 | Upgrade
|
| P/FCF Ratio | 8.12 | 18.29 | 10.30 | 7.67 | 25.46 | 10.83 | Upgrade
|
| P/OCF Ratio | 6.35 | 7.82 | 4.22 | 4.06 | 5.19 | 5.86 | Upgrade
|
| EV/Sales Ratio | - | 0.20 | 0.40 | 0.70 | 1.15 | 0.87 | Upgrade
|
| EV/EBITDA Ratio | - | 0.69 | 1.29 | 1.85 | 3.08 | 2.39 | Upgrade
|
| EV/EBIT Ratio | - | 1.03 | 1.65 | 2.12 | 3.51 | 2.79 | Upgrade
|
| EV/FCF Ratio | -0.10 | 2.21 | 3.29 | 3.87 | 16.67 | 5.45 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.01 | 0.04 | 0.00 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.04 | 0.11 | 0.34 | 0.02 | 0.05 | 0.01 | Upgrade
|
| Debt / FCF Ratio | 0.05 | 0.37 | 0.87 | 0.04 | 0.29 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.49 | -0.47 | -0.37 | -0.40 | -0.34 | -0.44 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.49 | -5.19 | -2.97 | -2.24 | -1.86 | -2.57 | Upgrade
|
| Net Debt / FCF Ratio | -8.23 | -16.71 | -7.58 | -4.67 | -10.07 | -5.86 | Upgrade
|
| Asset Turnover | 0.28 | 0.28 | 0.32 | 0.36 | 0.37 | 0.36 | Upgrade
|
| Inventory Turnover | 2.47 | 2.03 | 2.31 | 2.30 | 2.18 | 2.24 | Upgrade
|
| Quick Ratio | 4.18 | 3.38 | 2.24 | 1.59 | 1.72 | 2.69 | Upgrade
|
| Current Ratio | 4.78 | 3.97 | 2.57 | 1.87 | 2.17 | 3.23 | Upgrade
|
| Return on Equity (ROE) | 5.26% | 18.20% | 11.71% | 14.10% | 15.46% | 12.58% | Upgrade
|
| Return on Assets (ROA) | 2.61% | 3.31% | 4.73% | 7.47% | 7.62% | 7.04% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.04% | 10.03% | 12.72% | 21.48% | 21.80% | 22.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.80% | 5.80% | 9.30% | 15.30% | 14.40% | 13.20% | Upgrade
|
| Earnings Yield | 11.09% | 32.81% | 22.80% | 20.31% | 17.57% | 15.11% | Upgrade
|
| FCF Yield | 12.31% | 5.47% | 9.71% | 13.04% | 3.93% | 9.23% | Upgrade
|
| Dividend Yield | 5.48% | 5.60% | 8.85% | 8.25% | 6.42% | 6.63% | Upgrade
|
| Payout Ratio | 75.17% | 19.68% | 35.91% | 27.80% | 40.18% | 30.44% | Upgrade
|
| Buyback Yield / Dilution | -0.28% | -0.22% | -0.02% | 0.37% | 2.44% | 1.89% | Upgrade
|
| Total Shareholder Return | 5.15% | 5.38% | 8.83% | 8.62% | 8.85% | 8.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.